AR011251A1 - Metodo de utilizacion de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de neoplasias - Google Patents
Metodo de utilizacion de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de neoplasiasInfo
- Publication number
- AR011251A1 AR011251A1 ARP970104767A AR011251A1 AR 011251 A1 AR011251 A1 AR 011251A1 AR P970104767 A ARP970104767 A AR P970104767A AR 011251 A1 AR011251 A1 AR 011251A1
- Authority
- AR
- Argentina
- Prior art keywords
- hydroxyalkyl
- cycloalkyl
- alkyl
- inhibitors
- prevention
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 2
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 2
- 125000001188 haloalkyl group Chemical group 0.000 abstract 2
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000005097 aminocarbonylalkyl group Chemical group 0.000 abstract 1
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 1
- -1 carboxyalkylcarbonyl Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000392 cycloalkenyl group Chemical group 0.000 abstract 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 210000002919 epithelial cell Anatomy 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 150000004678 hydrides Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000036210 malignancy Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se relaciona con el uso de inhibidores de la ciclooxigenasa-2 o sus derivados en la prevencion y tratamiento de neoplasias. En particular, describeun método para prevenir y tratar neoplasias de células epiteliales en un sujeto , quecomprende tratar al sujeto con una cantidad eficaz en términosterapéuticos de un compuesto de formula I. Donde R2 se selecciona entre hidrido, alquilo, haloalquilo, alcoxicarbonilo, carboxialquilcarbonilo,carboxialquilo,aralcoxicarbonilalquilaminocarbonilo, aminocarbonilalquilo, alcoxicarbonilcianoalquenilo y hidroxialquilo; donde R3 se selecciona entrehidrido, alquilo, ciano, hidroxialquilo, cicloalquilo, alquilsulfonilo y halo;y donde R4 se selecciona entre aralquenilo, arilo, ci cloalquilo, cicloalqueniloy heterocíclico; donde R4 se sustituye optativamente en una posicion sustituible con uno o más radicales seleccionados entre halo, alquiltio,alquilsulfonilo,ciano, nitro, haloalquilo, alquilo, hidroxilo, alquenil o, hidroxialquilo, carboxilo, cicloalquilo, alquilamino, dialquilamino,alcoxicarbonilo, aminocarbonilo, alcoxi, haloalcoxi, sulfamilo, heterocíclico y amino; o una de sus sales aceptablespara uso farmacéutico o derivados.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2849496P | 1996-10-15 | 1996-10-15 | |
| US2849497P | 1997-10-15 | 1997-10-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR011251A1 true AR011251A1 (es) | 2000-08-16 |
Family
ID=45724874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970104767 AR011251A1 (es) | 1996-10-15 | 1997-10-15 | Metodo de utilizacion de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de neoplasias |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR011251A1 (es) |
-
1997
- 1997-10-15 AR ARP970104767 patent/AR011251A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2141916T3 (es) | Pirazolil-bencenosulfonamidas sustituidas para el tratamiento de la inflamacion. | |
| SV2002000287A (es) | Uso de inhibidor de la quinasa dependiente de la ciclina para preparar una composicion farmaceutica util para tratar enfermedades neurodegenerativas | |
| KR960701055A (ko) | 인터로이킨-1 및 종양 괴사 인자 억제 활성을 지닌 피라졸로트리아진 (pyrazol itriazines with interleukin-1 and tumour necrosis factor in-hibitory actvity) | |
| NO955256L (no) | Fenylheterosykluser som syklooksygenase-2-inhibitorer | |
| ATE205191T1 (de) | Guanidine derivate als inhibitoren des zellulären na+/h+ austauschmechanismus | |
| NZ503828A (en) | Aminothiazole inhibitors of cyclin dependent kinases | |
| NZ502370A (en) | Guanidine mimics for use as factor Xa inhibitors | |
| MXPA02011974A (es) | Derivados de quinazolina sustituidos y su uso como inhibidores. | |
| DK0731796T3 (da) | 1,3,5-Trisubstituerede pyrozolforbindelser til behandling af inflammation | |
| AU3126795A (en) | 3,4-substituted pyrazoles for the treatment of inflammation | |
| ATE211139T1 (de) | Tetrahydroimidazopyridoindoldione als cgmp spezifische pde hemmer | |
| ES2145996T3 (es) | Piridinas sustituidas con 3,4-diarilo para el tratamiento de la inflamacion. | |
| DE60034961D1 (de) | Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha | |
| MXPA02005844A (es) | Inhibidores de cinasas de proteina. | |
| BR1100931A (pt) | Compostos derivados de aril-heteroaril carbinóis, processos para a preparação dos compostos, composições farmacêuticas, e, uso dos compostos derivados de aril-heteroaril carbinóis | |
| DK0688315T3 (da) | Pyrrolidin- og oxazolidinderivater, deres fremstilling og deres anvendelse som trombocytaggregationsinhibitorer | |
| ATE359791T1 (de) | Pyrimidin-2,4-dion-derivate als matrix- metalloproteinase-hemmer | |
| DE60014404D1 (de) | Aminobenzophenone als inhibitoren von il-1beta und tnf-alpha | |
| PT920426E (pt) | Novos derivados de tiazole com efeito inibidor de fosfodiesterase | |
| DK0618193T3 (da) | Nitrogenholdige, bicycliske derivater som prolyl-endopeptidaseinhibitorer | |
| AU572660B2 (en) | Bis (4-aminophenyl) sulfones | |
| MX9400253A (es) | Derivados de piperazina, proceso para su preparacion y composiciones farmaceuticas que los contienen. | |
| DE69333285D1 (de) | 2-heterozyklisch-5-hydroxy-1,3-pyrimidinen verwendbar als entzündungswidrigesmittel | |
| DK1109560T3 (da) | Som AICARFT-inhibitorer anvendelige forbindelser | |
| AR011251A1 (es) | Metodo de utilizacion de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de neoplasias |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |